Skip to main content
. 2019 May 16;9:7495. doi: 10.1038/s41598-019-43965-2

Table 1.

Patient characteristics.

Overall patients Patients without HCC (n = 1177) Patients with HCC (n = 1071) P-value
Age at listing (years) 53.5 ± 9.1 51.7 ± 9.6 55.5 ± 7.9 <0.001
Male, n (%) 1650 (73.4%) 823 (69.9%) 827 (77.2%) <0.001
Blood type, n (%) 0.971
    A 776 (34.5%) 403 (34.2%) 373 (34.9%)
    B 654 (29.1%) 344 (29.2%) 310 (28.9%)
    AB 250 (11.1%) 134 (11.4%) 116 (10.8%)
    O 568 (25.3%) 296 (25.2%) 272 (25.4%)
Body mass index (kg/m2) 24.1 ± 3.5 24.0 ± 3.7 24.2 ± 3.3 0.12
Original liver disease, n (%) <0.001
    Hepatitis B virus 1595 (71.0%) 707 (60.1%) 888 (82.9%)
    Hepatitis C virus 200 (8.9%) 93 (7.9%) 107 (10.0%)
    Alcoholic 360 (16.0%) 304 (25.8%) 56 (5.2%)
    Cholestatic 40 (1.8%) 37 (3.1%) 3 (0.3%)
    Others 53 (2.3%) 36 (3.1%) 17 (1.6%)
CTP class, n (%) <0.001
    A 374 (16.6%) 79 (6.7%) 295 (27.5%)
    B 938 (41.7%) 397 (33.7%) 541 (50.6%)
    C 936 (41.7%) 701 (59.6%) 235 (21.9%)
MELD score 17.1 ± 8.9 20.5 ± 9.2 13.4 ± 6.6 <0.001
Status*, n (%) <0.001
    2A 159 (7.1%) 122 (10.4%) 37 (3.5%)
    2B 1395 (62.1%) 665 (56.5%) 730 (68.2%)
    3 694 (30.8%) 390 (33.1%) 304 (28.3%)

*Status based on previous Korean liver allocation system.